Main sector:
Biotechnology - Therapeutics and Diagnostics
Indications:
Neoplasms / cancer / oncology
Endocrine, nutritional and metabolic diseases / endocrinology
Digestive system / gastroenterology
Musculoskeletal system and connective tissue / Orthopedics
Genitourinary system / Urology
Products
In development: 12
On the market: 2
Description:
PegBio Co., Ltd. is a bio-medicine company focusing on the development of innovative drugs. The company is fully deployed in the fields of type II diabetes, non-alcoholic fatty liver, gout, constipation and cardiovascular, and has formed a series of product pipelines that can be used alone or in combination. Many of the company's products have entered the clinical research phase, among which the core products have already started clinical phase III trials. In addition, the company's multiple...
